首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Revista de investigacion clinica-clinical and translational investigation

缩写:REV INVEST CLIN

ISSN:0034-8376

e-ISSN:2564-8896

IF/分区:2.0/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引4104
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Gill Katelyn,Laney Iv Dan F,Ferral Hector Gill Katelyn
Random renal biopsy is considered the gold standard for the diagnosis of systemic renal disorders. Percutaneous biopsy remains a safe option for most patients; however, the percutaneous approach may be considered too risky in approximately ...
Stephanie Ortiz-Gómez,Paula Ruiz-Talero,Oscar Muñoz Stephanie Ortiz-Gómez
Background: Several models have been developed to assess bleeding risk in patients with venous thromboembolism, such as HAS-BLED, but their external validity has not been adequately assessed. ...
Tao Chen,Kenzi Shi,Shengrong Sun Tao Chen
Background: Triple-negative breast cancer (TNBC) represents the most aggressive subtype of breast cancer (BC), characterized by a dismal prognosis. Dysregulated long non-coding RNA LINC01614 might be a potential biomarker...
Amado Jiménez-Ruiz,Naomi N Becerra-Aguiar,Victor Aguilar-Fuentes et al. Amado Jiménez-Ruiz et al.
Background: The leading cause of spontaneous intracerebral hemorrhage (ICH) is hypertensive arteriolopathy. In addition to age and hypertension history, patients usually present other comorbidities that potentially increa...
Yihui Luo,Zhenchang Wang,Jun&#x;e Jiang et al. Yihui Luo et al.
Background: Hepatocellular carcinoma (HCC) is one of the most aggressive cancers worldwide. Curzerene is a sesquiterpene and component of Curcuma rhizomes and has anti-tumor and anti-inflammatory properties. ...
Mayela Rodríguez-Violante,Ana J Hernández-Medrano,Amin Cervantes-Arriaga et al. Mayela Rodríguez-Violante et al.
Monotherapy is the recommended initial treatment for early Parkinson's disease. The pharmacological options for initial treatment include dopaminergic agonists, monoamine oxidase B inhibitors, and levodopa formulations. Several factors shou...
Vera T Vega-Angeles,Valeria Morales-Ruiz,Laura V Adalid-Peralta Vera T Vega-Angeles
Background: Immunomodulatory drugs and immunotherapies are being evaluated in clinical trials for the treatment of neuroinflammation, as the latter is an essential mechanism for the development and progression of Parkinso...